Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Nisshin Flour Milling describes agents for septic shock

Aug. 16, 1996

P-selectin inhibitors reported by BMS

Aug. 16, 1996

MGI Pharma issued Israeli marketing approval for Salagen line extension

Aug. 9, 1996

Palauolol: A novel antiinflammatory phospholipase A2 inhibitor

Aug. 9, 1996

Niacinamide development update

Aug. 9, 1996

Japan Tobacco describes cell adhesion inhibitors

Aug. 9, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

World's first clinical trial on gene therapy for arthritis underway

July 26, 1996

Matrix metalloproteinase inhibitors described by British Biotech

July 26, 1996

Monoclonal antibody fragments as immunosuppressants

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.